Journal article
Etretinate Blood Levels in Monitoring of Compliance and Contamination in a Chemoprevention Trial
Abstract
We measured serum etretinate to monitor compliance in an ongoing chemoprevention trial in which heavy smokers are randomized to either etretinate or placebo orally for 6 months. Blood is collected for determination of etretinate levels before treatment and then at 2, 4, 8, 16, and 24 weeks after randomization. The monitoring strategy was assessed by interim evaluation. There were 276 posttreatment samples available from 75 randomized subjects …
Authors
Browman GP; Arnold A; Booker L; Johnstone B; Skingley P; Levine MN
Journal
Journal of the National Cancer Institute, Vol. 81, No. 10, pp. 795–798
Publisher
Oxford University Press (OUP)
Publication Date
May 22, 1989
DOI
10.1093/jnci/81.10.795
ISSN
0027-8874